Key facts
- Ramachandran Murali has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $329,481.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ramachandran Murali
- Location
- Beverly Hills, CA
- Summary
- The estimated net worth of Ramachandran Murali is at least $329,481 dollars as of 26 Nov 2025. Ramachandran Murali is the VP of Research and Development of Kairos Pharma, LTD. and owns shares of Kairos Pharma, LTD. (KAPA) stock worth about $329.5K.
- Signature
- /s/ Ramachandran Murali
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ramachandran Murali and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Kairos Pharma, LTD. ($329,481).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ramachandran Murali
KAPA
Forms 3/4/5
Kairos Pharma, LTD.
- Relationship
- VP of Research and Development
- Holdings value
- $329,481
- Past year net change
- Change %
- Report period
- 08 Oct 2025
Insider Transactions Reported by Ramachandran Murali:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.